Trade Surface Oncology - SURF CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.05 |
| Open | 1.02 |
| 1-Year Change | -21.54% |
| Day's Range | 0.99 - 1.05 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 7, 2023 | 1.05 | 0.03 | 2.94% | 1.02 | 1.05 | 0.99 |
| Sep 6, 2023 | 1.05 | 0.07 | 7.14% | 0.98 | 1.08 | 0.98 |
| Sep 5, 2023 | 0.99 | -0.06 | -5.71% | 1.05 | 1.05 | 0.98 |
| Sep 1, 2023 | 1.06 | 0.02 | 1.92% | 1.04 | 1.08 | 1.02 |
| Aug 31, 2023 | 1.05 | 0.03 | 2.94% | 1.02 | 1.06 | 1.01 |
| Aug 30, 2023 | 1.04 | 0.02 | 1.96% | 1.02 | 1.06 | 1.02 |
| Aug 29, 2023 | 1.03 | 0.07 | 7.29% | 0.96 | 1.04 | 0.96 |
| Aug 28, 2023 | 0.98 | 0.03 | 3.16% | 0.95 | 0.98 | 0.92 |
| Aug 25, 2023 | 0.93 | 0.02 | 2.20% | 0.91 | 0.93 | 0.91 |
| Aug 24, 2023 | 0.93 | 0.02 | 2.20% | 0.91 | 0.93 | 0.89 |
| Aug 23, 2023 | 0.92 | 0.00 | 0.00% | 0.92 | 0.96 | 0.92 |
| Aug 22, 2023 | 0.89 | -0.01 | -1.11% | 0.90 | 0.92 | 0.87 |
| Aug 21, 2023 | 0.90 | 0.02 | 2.27% | 0.88 | 0.92 | 0.87 |
| Aug 18, 2023 | 0.88 | 0.05 | 6.02% | 0.83 | 0.89 | 0.83 |
| Aug 17, 2023 | 0.86 | -0.02 | -2.27% | 0.88 | 0.89 | 0.85 |
| Aug 16, 2023 | 0.88 | -0.01 | -1.12% | 0.89 | 0.90 | 0.88 |
| Aug 15, 2023 | 0.89 | 0.01 | 1.14% | 0.88 | 0.89 | 0.86 |
| Aug 14, 2023 | 0.88 | -0.02 | -2.22% | 0.90 | 0.91 | 0.87 |
| Aug 11, 2023 | 0.91 | -0.01 | -1.09% | 0.92 | 0.92 | 0.90 |
| Aug 10, 2023 | 0.92 | 0.02 | 2.22% | 0.90 | 0.94 | 0.90 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Surface Oncology Company profile
About Surface Oncology Inc
Surface Oncology, Inc. is a clinical-stage, immuno-oncology company focused on developing antibody therapies focused on the tumor microenvironment. The Company is developing multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable an immunologic response and enhance outcomes for patients with cancer. Its pipeline includes two wholly owned clinical-stage programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a pre-clinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). In addition, Surface has two partnerships with pharmaceutical companies, including a collaboration with Novartis targeting CD73 (NZV930; Phase I) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813; preclinical).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Surface Oncology Inc revenues decreased 98% to $2.7M. Net loss totaled $78.5M vs. income of $59.3M. Revenues reflect License-related revenue decrease of 97% to $2.7M, Collaboration revenue - related party decrease from $38.6M to $0K. Net loss reflects Research and development - Balancing increase of 34% to $48.5M (expense), Stock-based Compensation in SGA increase of 24% to $6.1M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
50 Hampshire Street, 8Th Floor
CAMBRIDGE
MASSACHUSETTS 02139
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com